Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia

J Clin Oncol. 2013 Feb 20;31(6):e69-72. doi: 10.1200/JCO.2012.44.2020. Epub 2012 Nov 5.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / immunology
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Cachexia / complications
  • Cachexia / diagnosis
  • Cachexia / drug therapy*
  • Carcinoma, Large Cell / complications
  • Carcinoma, Large Cell / diagnosis
  • Carcinoma, Large Cell / therapy*
  • Combined Modality Therapy
  • Fatal Outcome
  • Humans
  • Lung Neoplasms / complications
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / therapy*
  • Male
  • Receptors, Interleukin-6 / immunology*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Receptors, Interleukin-6
  • tocilizumab